Long-term follow-up post SARS-CoV-2 / COVID-19 infection (SARS-CoV-2-Follow-Up)

Long-term follow-up post SARS-CoV-2 / COVID-19 infection (SARS-CoV-2-Follow-Up) - SARS-CoV-2-Follow-Up

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025089

Enrollment

500

Registered

2021-04-19

Start date

2020-08-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U09.9

Interventions

Group 1: There is a follow-up every 3 months after acute COVID-19 with lab values, clinical examination, symptom query, blood pressure and pulse measurement and SF-12 query (query of the quality of li

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with confirmed SARS-Cov-2infection, written infomed consent

Exclusion criteria

Exclusion criteria: age <18 years

Design outcomes

Primary

Measure	Time frame
Prospective register of patients after COVID-19 in combination with biobanking. The primary aim of the study is to characterize Long-COVID	—

Secondary

Measure	Time frame
Long-term follow-up	—

Countries

Germany

Contacts

Public ContactUta Merle

Universitätsklinikum Heidelberg

uta.merle@med.uni-heidelberg.de004962215638709

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026